chart-review-psma-context

name

chart-review-psma-context

description

PSMA PET/CT clinical-context chart review. Activate when assembling the prostate-cancer context a radiologist needs to interpret a PSMA PET/CT — Grade Group, PSA + trend, prior metastatic sites, treatment history (prostatectomy, radiation, ADT, ARPI, chemo, radioligand), the scan indication, and prior-imaging status — answering the PC0–PC3 chart-review questions per patient from pathology, oncology, urology, radiation-oncology, and prior imaging notes plus structured EHR data.

PSMA PET/CT context — chart review

For each in-scope patient you answer the FACTUAL questions in references/questions/ (the PC0–PC3 checklist). This task provides clinical context for the interpreting radiologist; it does NOT judge the scan or make recommendations, so there are no concordance rules to compute.

Procedure

1. Eligibility (eligibility.yaml, T0): confirm this exam is a PSMA PET/CT and the patient has confirmed prostate adenocarcinoma. Answer first.
2. Disease + staging (disease.yaml, T1): Grade Group, most-recent PSA + trend, prior metastatic sites.
3. Treatment history (treatment.yaml, T2): prostatectomy, radiation, and the STATE (none/active/completed) of ADT, ARPI, chemotherapy, plus prior radioligand therapy. Report state, not merely presence — ADT suppresses PSMA avidity and changes interpretation.
4. Exam context (exam.yaml, T3): the indication for THIS scan, the prior PET/CT disease status, and any prior-imaging follow-up recommendation (quote it verbatim).
5. Cite evidence for every answer: a verbatim note quote (pathology / oncology / radiology), or a structured row (PSA lab / medication / procedure) when that is the source. Answer with the exact enum token; put detail (dates, drug names, Gleason pattern) in the rationale. If the chart is silent, answer unclear — never infer from general knowledge.